Cite
HARVARD Citation
Scher, H. et al. (2021). Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer. European journal of cancer. pp. 83-94. [Online].